INTS vs REGN: Which Stock is Better?

Side-by-side comparison of Intensity Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

INTS

Intensity Therapeutics Inc

$5.50

REGN

Regeneron Pharmaceuticals Inc

$746.46

Key Metrics Comparison

MetricINTSREGNWinner
Market Cap$13.87M$79.17BREGN
P/E RatioN/A18.05REGN
EPS (TTM)$N/A$41.49REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze INTS

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is INTS or REGN a better investment?

Comparing INTS and REGN: Intensity Therapeutics Inc has a market cap of $13.87M while Regeneron Pharmaceuticals Inc has $79.17B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between INTS and REGN?

INTS (Intensity Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: INTS or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: INTS or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for INTS.

Which company is more profitable: INTS or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for INTS.

Which is the larger company: INTS or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.17B compared to $13.87M for INTS.

Should I buy INTS or REGN in 2026?

Both INTS and REGN have investment merit. INTS trades at $5.50 while REGN trades at $746.46. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between INTS and REGN stock?

Key differences: Market Cap ($13.87M vs $79.17B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons